Evolution of Approval, Regulation Processes for Drugs Explored
FDA drug review times down from 1983 to 2017, but time from clinical testing to approval did not change
AI System Can Detect, Grade Cancer in Prostate Needle Biopsy
AUCs were 0.997, 0.986 for distinguishing between benign, malignant biopsy cores, respectively
FDA: Weight Control Drug Lorcaserin May Raise Cancer Risk
Health care providers should balance the benefits of taking lorcaserin against the potential risks
Doctor Replacement Ratios Higher in Largest, Hospital-Owned Practices
More than double the number of physicians entered than exited large group, hospital-owned practices
Cancer Incidence Up in World Trade Center Responder Cohort
Incidence up for all cancer sites combined and for prostate cancer, thyroid cancer, leukemia
Vaccine Program Recovery Difficult After Public Scares
Misinformation is threat to resilience of vaccination programs globally, authors say
Notification Laws May Not Increase Knowledge of Dense Breast Risks
Women with lower education may be less likely to gain awareness of breast density due to the laws
Nonalcoholic Steatohepatitis Will Pose Clinical, Economic Burden
Model predicts rising costs for care of U.S. patients with NASH and T2DM over next 20 years
Alcohol Consumption Levels High in Cancer Patients, Survivors
One in five patients report binge drinking, while one-third exceed moderate drinking levels
Burnout in Med Students Tied to Perceived Stress, Phone Behavior
Majority of osteopathic medical students report low sense of personal accomplishment
